HNRNPH2 and cancer: Members of the hnRNP H/F family (including hnRNP H1, hnRNP H2, HnRNP H3, hnRNP F) are among the most deregulated RBPs in several types of cancers [12,31], including GBM [26,32], where they represent likely clinically relevant molecular targets [26].